Protein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
4 years agoProtein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
4 years ago
Evaluating Advancements in Drug Discovery
Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...
4 years agoEvaluating Advancements in Drug Discovery
Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...
4 years ago
Machine Learning Data Analysis: Applications Across Immunology, Oncology and Diabetes
Computational modelling is becoming increasingly popular for data analysis in life sciences. Vast areas of therapeutic research are taking advantage of machine learning (ML) approaches for disease predictions and pathology. Cancer image analysis and diabetes case prediction are a few...
4 years agoMachine Learning Data Analysis: Applications Across Immunology, Oncology and Diabetes
Computational modelling is becoming increasingly popular for data analysis in life sciences. Vast areas of therapeutic research are taking advantage of machine learning (ML) approaches for disease predictions and pathology. Cancer image analysis and diabetes case prediction are a few...
4 years ago
Understanding the GP Data Extraction Scheme & Use of Patient Data
The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...
4 years agoUnderstanding the GP Data Extraction Scheme & Use of Patient Data
The General Practice Data for Planning and Research (GPDPR) is a proposed central NHS digital database collating patient data from GP records in England. Originally 1 July 2021, the date for launch has been pushed back to 1 September after...
4 years ago
Aseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
4 years agoAseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
4 years ago
Another Direction for Clinical Oncology: Targeting the Anti-Inflammatory Response in Cancer
Approximately 15-20% of all cancer cases are preceded by infection, chronic inflammation, or autoimmunity at the same tissue or organ site. While inflammation is a natural response to tissue damage, chronic inflammation can become pathological. The role of inflammation in...
4 years agoAnother Direction for Clinical Oncology: Targeting the Anti-Inflammatory Response in Cancer
Approximately 15-20% of all cancer cases are preceded by infection, chronic inflammation, or autoimmunity at the same tissue or organ site. While inflammation is a natural response to tissue damage, chronic inflammation can become pathological. The role of inflammation in...
4 years agoInterested?
Reserve your space
